Jim Cramer's top 10 things to watch in the stock market Tuesday

UnitedHealth posted a beat-and-raise quarter, with its medical benefit ratio at 83.9% versus 85.5% expected and at least $2 billion of buybacks planned by end-Q2. GE Aerospace beat expectations with orders up 87% to $23 billion and revenue up 25% to $12.39 billion, while Apple named John Ternus as Tim Cook’s successor on Sept. 1. The note also highlighted Amazon’s additional $5 billion Anthropic investment, a KeyBanc upgrade of CrowdStrike to buy, and bullish analyst calls on AbbVie, Coherent, Alphabet, and Meta ahead of next week’s Big Tech earnings.

Analysis

The market setup is being pulled by a handful of very different duration trades at once: near-term risk appetite from healthcare and semis/AI infra, and a medium-term capex reacceleration story in cloud and data-center buildouts. The important second-order effect is that capital is concentrating into firms that can turn AI demand into either monetizable software spend (GOOGL, META, MSFT, AMZN) or necessary physical bottlenecks (COHR, GLW), while pure compute beneficiaries remain more vulnerable to margin compression if hyperscalers keep negotiating harder on supply. That argues for owning the enablers, not the obvious demand proxies.

Apple’s CEO transition is less about a one-day headline and more about signaling continuity in hardware-led AI execution. If the market believes product cadence stays intact, the real beneficiary may be the broader supplier ecosystem rather than AAPL itself; a smoother transition reduces the odds of a strategic reset, which keeps spending patterns stable across component vendors. The contrarian read is that the stock can remain range-bound if investors decide the handoff removes some scarcity premium from governance, even if fundamentals stay strong.

Healthcare is splitting into clear winners and laggards. UNH’s beat-and-raise plus buyback support lowers near-term regulatory and sentiment risk, but it also raises the bar for managed-care peers because investors will now compare execution quality against a cleaner operating baseline. In biotech, ABBV’s reset to core-holding status is less about valuation and more about durability of cash flow; that can compress the relative premium on slower-growing large-cap pharma names, especially if immunology share shifts continue. GE’s selloff looks like the market focusing on aerospace timing risk rather than earnings quality, creating a possible overreaction if defense budgets and commercial backlog convert as expected.

The biggest tactical setup is around next week’s megacap earnings. The market is underpricing the probability that AI monetization shows up first as margin leverage rather than explosive revenue, which supports long GOOGL/META versus short a basket of AI beneficiaries with weaker pricing power. Cybersecurity is another second-order winner: if AI lowers attack barriers, enterprise security budgets become less discretionary, making CRWD an attractive relative long even if the software group gets choppy.

Key Decisions for Investors

• Go long CRWD into the next 2-6 weeks on the thesis that AI-driven attack surface expansion lifts security budgets faster than broader software demand; target a 10-15% upside with a tight thesis stop if enterprise spend weakens.
• Buy GOOGL and META on any pre-earnings weakness into Apr. 29, and consider a paired short against lower-quality AI monetization names; expect 5-8% upside if search/cloud and ad AI lift margins rather than just revenue.
• Take a relative long position in UNH vs. managed-care peers for 1-3 months; the beat-and-raise plus repurchases improves sentiment durability, with downside limited unless medical cost trend reaccelerates.
• Use GE weakness to initiate a tactical long over the next 1-2 weeks if the market is over-discounting guidance; risk/reward favors a rebound if defense order momentum and backlog conversion remain intact.
• Add COHR or GLW as a medium-term AI-infrastructure pair trade versus NVDA; the trade benefits from rising optical content per data center while reducing exposure to compute pricing pressure.